Emergent BioSolutions Canada Inc.
Registration:
13
of
13
(2024-07-01
to
present)
Details Regarding the Identified Subject Matter
Subject matters
|
Details
|
Categories
|
Health, Industry, Research and Development
|
Eligibility for Scientific Research and Experimental Development tax incentives.
|
Grant, Contribution or Other Financial Benefit
|
Government Procurement, Health, Industry, Research and Development
|
Seek funding support from the Strategic Innovation Fund to expand Emergent's Winnipeg facility.
|
Grant, Contribution or Other Financial Benefit
|
Aboriginal Affairs, Consumer Issues, Defence, Government Procurement, Health, Justice and Law Enforcement, Research and Development
|
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
|
Policies or Program
|